Muscular Dystrophies - 49 Studies Found
Recruiting |
: An Extension Study to Assess Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD) : Duchenne Muscular Dystrophy : 2016-04-28 :
|
Recruiting |
: A Study to Assess Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD) : Duchenne Muscular Dystrophy : 2016-04-28 :
|
Enrolling by invitation |
: Long-term Extension Study to Assess Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD) : Duchenne Muscular Dystrophy : 2017-01-30 :
|
Not yet recruiting |
: Clinical Trial to Evaluate the Efficacy, Safety, and Tolerability of BMS-986089 in Ambulatory Boys With Duchenne Muscular Dystrophy : Duchenne Muscular Dystrophy : 2017-01-27 :
|
Active, not recruiting |
: Dose-Titration and Open-label Extension Study of SRP-4045 in Advanced Stage Duchenne Muscular Dystrophy (DMD) Patients : Duchenne Muscular Dystrophy : 2015-08-10 :
|
Recruiting |
: The Study of Skeletal Muscle Blood Flow in Becker Muscular Dystrophy : Muscular Dystrophy : 2015-12-14 :
|
Completed |
: Stem Cell Therapy in Duchenne Muscular Dystrophy : Duchenne Muscular Dystrophy : 2014-09-12 : Biological: Stem Cell Intrathecal autologous bone marrow mononuclear cell transplantation |
Completed |
: The Efficacy of Using Far Infrared Radiation to Manage Muscular Dystrophies : Muscular Dystrophies : 2008-05-06 : Radiation: Far Infrared Radiation Radiation: Far Infrared Radiation (5μm to 20μm wavelength) F |
Active, not recruiting |
: Sunphenon Epigallocatechin-Gallate (EGCg) in Duchenne Muscular Dystrophy : Duchenne Muscular Dystrophy : 2010-08-17 :
|
Completed |
: Safety Study of Flavocoxid in Duchenne Muscular Dystrophy : Duchenne Muscular Dystrophy : 2011-04-12 : Drug: Flavocoxid Flavocoxid capsules TTD 500 mg/die or 1000 mg/die for 1 year |